Sol-Gel Technologies Ltd. is a pharmaceutical company specializing in dermatological treatments utilizing its proprietary aerosol-based, drug-delivery platform. Founded in 1997 and headquartered in Israel, Sol-Gel develops topical dermatology products to address common skin conditions such as acne and rosacea. The company's innovative approach leverages nanotechnology to create microencapsulation systems that improve drug efficacy, stability, and patient experience. By focusing on these prevalent conditions, Sol-Gel plays a vital role in the pharmaceutical sector, particularly in advancing topical treatment technologies. With a commitment to research and development, Sol-Gel Technologies seeks collaborations and partnerships to further enhance its product pipeline and expand its market presence, contributing significantly to the dermatology therapeutics industry.